5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.27▼ | 2.29▼ | 2.29▼ | 2.37▼ | 2.13▲ |
MA10 | 2.31▼ | 2.32▼ | 2.33▼ | 2.26▼ | 2.04▲ |
MA20 | 2.36▼ | 2.46▼ | 2.44▼ | 2.21▲ | 1.93▲ |
MA50 | 2.46▼ | 2.38▼ | 2.34▼ | 2.05▲ | 1.99▲ |
MA100 | 2.37▼ | 2.26▼ | 2.22▲ | 1.91▲ | 2.25▼ |
MA200 | 2.26▼ | 2.11▲ | 2.05▲ | 1.91▲ | 2.50▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.015▼ | -0.030▼ | -0.038▼ | 0.004▲ | 0.053▲ |
RSI | 38.336▼ | 41.902▼ | 43.966▼ | 52.007▲ | 55.882▲ |
STOCH | 27.273 | 28.860 | 5.641▼ | 35.382 | 49.838 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -85.185▼ | -58.974 |
CCI | -126.756▼ | -174.645▼ | -80.769 | -1.697 | 186.550▲ |
Friday, September 05, 2025 07:10 AM
Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ADG126 will be highlighted in two ...
|
Tuesday, August 26, 2025 05:12 AM
Adagene Inc. ('Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chief Strategy Officer, ...
|
Thursday, August 21, 2025 08:24 AM
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adagene Inc. Sponsored ADR (ADAG) been one of those stocks ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
12/09/25 | 2.35 | 2.41 | 2.23 | 2.24 | 97,683 |
11/09/25 | 2.40 | 2.49 | 2.34 | 2.34 | 85,371 |
10/09/25 | 2.34 | 2.45 | 2.24 | 2.39 | 192,997 |
09/09/25 | 2.39 | 3.16 | 2.31 | 2.50 | 534,600 |
08/09/25 | 2.26 | 2.428 | 2.26 | 2.39 | 58,479 |
05/09/25 | 2.11 | 2.45 | 2.11 | 2.20 | 129,701 |
04/09/25 | 2.12 | 2.20 | 2.12 | 2.14 | 40,252 |
03/09/25 | 2.12 | 2.24 | 2.11 | 2.18 | 41,416 |
02/09/25 | 2.12 | 2.20 | 2.12 | 2.12 | 16,979 |
29/08/25 | 2.17 | 2.24 | 2.08 | 2.13 | 33,204 |
|
|
||||
|
|
||||
|
|